The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 15.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 46%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (2 analysts) rates it buy, with a mean price target of $8.
Liberty Latin America Ltd.
LILAK · Nasdaq · USD · Market cap $1.7B · 9,000 employees
Liberty Latin America Ltd., together with its subsidiaries, provides fixed, mobile, and subsea telecommunications services in Puerto Rico, Panama, Costa Rica, Jamaica, Latin America and the Caribbean, the Bahamas, Trinid…
FAIL · Does not pass the screenPrice as of 13 Nov 2026Daily close, not a live quoteLast reviewed 4 days ago
Screened 2026-11-13 · the tape above runs as of 06:11 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price9.86 USD at the 13 Nov 2026 close
- Our value readOvervalued vs our fair value, as of 13 Nov 2026
- Our regime readMarkup, as of 15 Nov 2026
- Ethical screenDoes not pass
- OptionsOpen interest leans heavily to calls (put/call 0.50)
- Last reviewed13 Nov 2026 (4 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $4.93 to $6.27, base estimate $5.46 (screen dated 2026-11-13).
- Trend Markup
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 0.50, read 2026-11-14
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markup label.
Liberty Latin America Ltd. holds its Markup at $9.86. The statistical read favours the sellers, held for 61 days.
| Phase | Markup |
| Quantitative state | The statistical read favours the sellers, held for 61 days |
| Price at the screen | $9.86 |
| Valuation | N/A trailing · 21.00 forward price to earnings |
| Values screen | FAIL · score 70.0 |
| Beta | 0.78 |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 68.50% | Below 33% | Interest-bearing debt is 68.5% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 11.76% | Below 49% | Money owed to the company is 11.8% of assets, under the 49% limit. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Falls Short, in Plain English
Liberty Latin America's business is in a permissible area, but its interest-bearing debt is about 68% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-15. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when LILAK's ethical verdict changes
Today LILAK does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our analysis reads Overvalued vs our fair value, as of 13 Nov 2026: it trades above our $5.46 fair value estimate, 1.50% revenue growth.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-13 screen. The gold marker is the market price at the same screen. The price runs 80.6% above the base estimate.
Third-party analyst targets. The average target sits −27% from the screen price.
Reading the gap · Both our model and the Street see limited upside at this price.
Price History & ProjectionsWhere our models see it going: fair-value estimate $5.46, with a range of $4.93 to $6.27, dated to the 2026-11-13 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsCaribbean Telecom Trades Well Above Fair Value
Picture a phone network strung across hurricane-prone islands where every connection costs more to maintain than it brings in. Liberty Latin America delivers fixed and mobile services across Puerto Rico, Jamaica and a string of Caribbean and Latin American markets, yet it posted flat revenue, an 11% negative profit margin and a 35% negative return on equity. The shares sit at 7.33 dollars against our 5.20 dollar fair value, leaving no margin of safety and an opportunity rating of none.
We pass because the business shows no growth momentum and continues to destroy capital at a time when its forward multiple of 17.9 times offers no discount for those risks. Two analysts rate the stock a hold with a median target of 7 dollars, which simply lines up with the current price rather than signalling upside.
Currency swings, regulatory pressure and intense local competition remain live threats in these markets, and the lack of a clear moat leaves little room for error. The ethical screen is passed, yet the financial picture still fails our test.
Analysis, not advice.
| Forward P/E | 21.0xexpensive even after accounting for its growth |
| EPS, trailing | -0.49 |
| EPS, forward | 0.41 |
| Revenue growth | +1.5%slow but positive growth |
| Profit margin | -2.2%currently unprofitable |
| Return on equity | -3.7%not currently earning a positive return on equity |
| FCF yield | 25.57% |
| Debt to equity | 9.06heavy leverage: higher risk if revenue softens |
| Current ratio | 1.19adequate liquidity, worth monitoring |
| Beta | 0.78steadier than the market |
| Short interest, float | 0.05% |
| 52-week range | 4.61 - 9.00 |
| Market cap | $1.7B |
| Employees | 9,000 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; its business and earnings are exposed to Bermuda and to currency swings; it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeLILAK trades on Nasdaq (the company is based in Bermuda). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 3.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 46%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (2 analysts) rates it buy, with a mean price target of $8. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 46%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (2 analysts) rates it buy, with a mean price target of $8. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 46%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (2 analysts) rates it buy, with a mean price target of $8. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 4.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 46%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (2 analysts) rates it buy, with a mean price target of $8. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 46%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (2 analysts) rates it buy, with a mean price target of $8. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 46%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (2 analysts) rates it buy, with a mean price target of $8. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 0.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 46%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (2 analysts) rates it buy, with a mean price target of $8. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 46%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (2 analysts) rates it buy, with a mean price target of $8. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 3.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 46%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (2 analysts) rates it buy, with a mean price target of $8. Since the last review it entered the Titan Ethical 500.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Why Liberty Latin America Rose Even Though It Swung To A Loss Yahoo Finance · 4d ago
- Liberty Latin America Ltd (LILA) (Q3 2026) Earnings Call Highlights: Subscriber Growth ... Yahoo Finance · 4d ago
- Liberty Latin (LILA) Q3 2026 Earnings Call Transcript Yahoo Finance · 8d ago
- What Liberty Latin America (LILA) Said on Its Q3 Earnings Call Yahoo Finance · 11d ago
- Liberty Latin America Ltd. Q3 2026 Earnings Call Summary Yahoo Finance · 12d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $7.88 | -0.1% | · | $999 | -0.1% |
| 2 months | $8.28 | -4.9% | · | $951 | -4.9% |
| 3 months | $7.71 | +2.1% | · | $1,021 | +2.1% |
| 6 months | $8.77 | -10.2% | · | $898 | -10.2% |
| 1 year | $5.39 | +46.1% | · | $1,461 | +46.1% |
| 2 years | $8.83 | -10.8% | · | $892 | -10.8% |
| 3 years | $7.90 | -0.3% | · | $997 | -0.3% |
| 5 years | $14.05 | -44.0% | · | $561 | -44.0% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever LILAK does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.